Efficacy and safety of dulaglutide monotherapy compared with glimepiride in Chinese patients with type 2 diabetes: Post-hoc analyses of a randomized, double-blind, phase III study.
Li Xin ShiXiao Min LiuYong Quan ShiQuan Min LiJian Hua MaYan Bing LiLi Ying DuFeng WangLu Lu ChenPublished in: Journal of diabetes investigation (2019)
These findings support once-weekly dulaglutide monotherapy as a treatment for Chinese patients with early stage type 2 diabetes.